Results from recent evidences demonstrate that tumor cell-intrinsic PD-1 can activate mTOR signal in liver cancer and combination therapy targeting mTOR pathways and PD-1 may have a better clinical efficacy 37. This evidence concerns the gene MTOR and neoplasm.